Mode
Text Size
Log in / Sign up

Pelvic floor physiotherapy improves quality of life and reduces painful defecation in pediatric functional constipationWhen Laxatives Are Not Enough, This Therapy May Help Kids

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider pelvic floor physiotherapy as a promising adjuvant for pediatric functional constipation, noting limitations in long-term data.

This systematic review and meta-analysis evaluated the efficacy of pelvic floor physiotherapy in managing functional constipation among pediatric and adolescent populations aged 18 years or younger. The analysis synthesized data from seven randomized controlled trials, encompassing a total sample size of 775 participants. Study settings and specific protocols varied significantly across the included trials, with sample sizes ranging from 45 to 400 participants per trial. The intervention comprised various physiotherapeutic modalities, including pelvic floor exercises, biofeedback, telerehabilitation, visceral mobilization, and electrostimulation. The comparator arm consisted of conventional medical treatment, which frequently involved co-intervention with polyethylene glycol (PEG). Follow-up periods across the studies were generally shorter than 12 months.

Regarding the primary outcome of defecatory frequency, the meta-analysis reported less consistent results. The mean difference was 1.00 with a 95% confidence interval ranging from 0.35 to 1.65. While the direction of the effect was generally positive, the heterogeneity in protocols and assessment instruments contributed to this variability. In contrast, secondary outcomes demonstrated more robust positive trends. Improvements were observed in fecal consistency and quality of life. Additionally, painful defecation showed significant improvement with the physiotherapeutic interventions compared to conventional management alone.

Safety and tolerability data were not reported in the included trials, nor were rates of adverse events, serious adverse events, or discontinuations documented. Consequently, the tolerability profile of the physiotherapeutic interventions remains unknown based on this specific evidence base. The absence of blinding for both participants and therapists in the original trials introduces potential performance and detection biases that could influence the reported outcomes.

When compared to prior landmark studies in pediatric functional constipation, this meta-analysis reinforces the role of non-pharmacologic interventions. However, the frequent co-intervention with PEG in the comparator groups complicates the interpretation of whether improvements are solely due to physiotherapy or the combined effect of standard medical care. The large effect size noted for reducing painful defecation and enhancing quality of life aligns with the broader therapeutic goal of improving patient comfort and daily functioning.

Key methodological limitations include marked heterogeneity in physiotherapy protocols regarding type, intensity, and duration. Variability in the instruments used to assess outcomes further complicates direct comparisons. The frequent use of PEG as a co-intervention limits the ability to isolate the specific contribution of physiotherapy. Furthermore, the short duration of follow-up raises questions regarding the long-term sustainability of the observed benefits. These factors collectively suggest that while the current evidence is encouraging, it is not yet definitive for long-term clinical adoption without further validation.

Clinically, these results support considering pelvic floor physiotherapy as a promising adjuvant intervention for pediatric functional constipation, particularly for addressing painful defecation and quality of life. However, practitioners must interpret these findings with caution due to the lack of long-term data and the heterogeneity of the intervention protocols. The evidence does not yet support a definitive recommendation for universal adoption without further high-quality trials. Questions remain unanswered regarding the optimal duration of therapy, the most effective specific modality among the various techniques tested, and the long-term maintenance of benefits after cessation of therapy.

Future research should prioritize multicenter trials with standardized protocols and larger sample sizes to reduce heterogeneity. Studies must also aim for longer follow-up periods to assess the sustainability of improvements. Additionally, efforts to blind participants and therapists, and to standardize assessment instruments, are necessary to minimize bias. Until such data are available, clinicians should integrate these findings into practice while remaining aware of the current evidence's limitations regarding efficacy confirmation and long-term outcomes.

The bathroom battle parents know too well

It is 7 a.m. on a school day. Your 8-year-old is crying in the bathroom again.

The pediatrician already prescribed polyethylene glycol, a common laxative sold as MiraLAX. It helps. Sort of. But the pain and the fear and the accidents keep coming back.

Functional constipation in kids is rarely just about fiber. It is a tangled mix of stretched-out bowels, muscles that have forgotten how to relax, and a child who now braces every time they sit on the toilet.

Functional constipation affects up to 1 in 3 children at some point. It is one of the top reasons families visit pediatric gastroenterologists.

Standard care is laxatives, diet changes, and toilet routines. That works for many kids. But a stubborn group stays stuck for years.

Their problem is not just the stool. It is the muscles of the pelvic floor (the sling of muscles that hold the bottom of the belly) refusing to relax on command.

The old way versus the new way

The old plan looked like this. Keep giving laxatives. Hope the muscles relearn on their own. Wait it out.

For many kids that took months or years. And the longer the cycle ran, the more shame and fear built up.

Here is the shift. A new systematic review pulled together seven randomized trials (the gold standard of research), with 775 children total, to test whether pelvic floor physiotherapy adds real value on top of normal medical care.

Think of it like learning to whistle

Imagine trying to teach a child to whistle by yelling instructions through a door. No feedback. No mirror. Just guesses.

That is how pooping works for a lot of constipated kids. They do not feel what their muscles are doing.

Pelvic floor physiotherapy opens the door. Through exercises, biofeedback (sensors that show muscle activity on a screen), gentle belly massage, and sometimes mild electrical stimulation, the child finally sees and feels what "relax" looks like.

It is not magic. It is coaching for muscles that never learned the job.

The review searched four major medical databases for randomized controlled trials comparing pelvic floor physiotherapy with standard medical treatment in children and adolescents.

Sample sizes ran from 45 to 400 kids per study. The interventions varied. Some used exercises alone. Others added biofeedback, telerehabilitation (therapy over video), visceral mobilization (a hands-on abdominal technique), or electrostimulation.

Study quality was judged with the PEDro scale, a standard tool for rating physical therapy research.

Across the trials, kids who got pelvic floor physiotherapy had less painful defecation, better stool consistency, and higher quality of life than kids on standard care alone.

The effect size was described as large for pain reduction. In plain English, this was not a subtle blip. Kids and parents noticed it.

One finding was less consistent. The number of bowel movements per week improved only modestly (about one extra per week on average). So kids pooped more comfortably, even if not always more often.

Pelvic floor therapy did not replace laxatives. It worked alongside them.

Where this fits in the bigger picture

Adult pelvic floor therapy has been mainstream for years, from postpartum recovery to incontinence. Pediatric use has lagged behind.

Part of the lag is practical. Few clinics have therapists trained for kids. Insurance coverage is spotty. And convincing a 7-year-old to do biofeedback exercises requires skill.

This review is the first to pool the pediatric numbers in a meta-analysis. It gives pediatricians something concrete to point to when referring families out.

If your child has been on laxatives for months without full relief, ask your pediatrician or pediatric GI doctor about pelvic floor physiotherapy.

Look for a therapist with specific pediatric pelvic floor training. Not every physical therapist has it.

This is not a quick fix. Expect several sessions over weeks or months. And expect to keep the laxative going in the meantime. Most trials combined the two.

Honest limitations

The seven trials used very different protocols. Some lasted weeks, others months. Some used biofeedback, others did not. That makes it hard to say which exact recipe works best.

Most studies followed kids for less than a year. We do not know if the benefits hold up over time.

Blinding was also tricky. Kids and therapists knew which treatment was being given, which can nudge the results.

The authors call for large, multicenter trials with standardized protocols and longer follow-up. That would answer two key questions. Which version of pelvic floor therapy works best? And does the benefit last into adulthood?

Meanwhile, expect more pediatric GI clinics to start bundling physiotherapy into their standard care plans. The evidence is not perfect, but it is strong enough to act on.

Study Details

Study typeMeta analysis
Sample sizen = 400
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
UNLABELLED: To evaluate the efficacy of physiotherapeutic interventions in the management of functional constipation (FC) in pediatric and adolescent populations, and to analyze the methodological quality of the available evidence. A systematic review of randomized controlled trials (RCTs) published in PubMed, Cochrane Library, Embase, and Web of Science was conducted (February-March 2025). Studies including participants aged 18 years diagnosed with FC, treated with pelvic floor physiotherapy versus conventional medical treatment, were included. Methodological quality was assessed using the PEDro scale (Physiotherapy Evidence Database). Seven clinical trials were included in the meta-analysis with sample sizes ranging from 45 to 400 participants (total n = 775). The interventions covered pelvic floor exercises, biofeedback, telerehabilitation, visceral mobilization, and electrostimulation. The majority showed improvements in painful defecation, fecal consistency, and quality of life, with less consistent results in defecatory frequency (MD = 1.00; 95% CI: 0.35 to 1.65). However, the marked heterogeneity in protocols (type, intensity, duration), variability in assessment instruments, and frequent co-intervention with polyethylene glycol (PEG) hinder comparison between studies and limit external validity. Follow-ups shorter than 12 months and the absence of blinding of participants and therapists constitute additional risks of bias. CONCLUSIONS: Pelvic floor physiotherapy appears to be a promising adjuvant intervention in the treatment of pediatric FC, with positive effects on symptoms and quality of life. Nevertheless, multicenter trials with standardized protocols, large samples, and prolonged follow-up are required to confirm its efficacy and long-term sustainability. WHAT IS KNOWN: •Despite the clinical use of physiotherapy, there was no quantitative synthesis integrating its efficacy against standard medical treatment, nor had its specific effect size on defecatory pain and quality of life been established in the pediatric population. WHAT IS NEW: •This meta-analysis confi rms that pelvic fl oor physiotherapy is an eff ective adjuvant with a large effect size, demonstrating consistent improvements in reducing painful defecation and enhancing the biopsychosocial dimensions of quality of life.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.